Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Gland Pharma has enclosed the Secretarial Compliance Report for the financial year ended 31st March, 2025 issued by RVR & Associates, Company Secretaries.
The above information is a part of company’s filings submitted to BSE.